Live Chat ×
Skip to main content

Getting to Gold with Parathyroid, Pituitary, Sphenoid and Neck Neuroendocrine Lesions

Evaluated by: David B. Kaminsky, M.D., FIAC on June 25, 2017
Original release date: November 15, 2017
Access to this course expires on: June 23, 2020
CME/SAMs 1.5

Faculty: Sylvia L. Asa, M.D., Ph.D.

Learning Objectives:

  • Recognize the morphologic and immunohistochemical features that distinguish benign from malignant lesions of thyroid and parathyroid.
  • Understand the spectrum of neuroendocrine tumors of the head and neck and their biomarkers.
  • Be familiar with genotype-phenotype correlations in endocrine neoplasia and the need for molecular testing for prognosis, prediction and determination of genetic predisposition.

To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.